Ralox is indeed a better choice for treating gyno. It has about 10x the binding affinity for the estrogen receptor in breast tissue than tamoxifen does. There's a study that proves Ralox is more beneficial than Nolva for that matter: ncbi.nlm.nih.gov/pubmed/15238910
Ralox is indeed a better choice for treating gyno. It has about 10x the binding affinity for the estrogen receptor in breast tissue than tamoxifen does. There's a study that proves Ralox is more beneficial than Nolva for that matter: ncbi.nlm.nih.gov/pubmed/15238910
Using my university's library database, I just found the full Nolva v. Raloxifene study. Dosages used were: "tamoxifen 10 to 20 mg orally twice a day for 3 to 9 months, or raloxifene 60 mg orally once daily for 3 to 9 months."
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.